Compound ID | 279
Class: Bis-indole
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Anti-tubercular (MDR TB (MIC ≤ 0.02-1.25 µg/mL) compounds synthesised by Microbiotix, the company seems to have moved onto research of spectinamides for MDR TB treatment |
Institute where first reported: | Microbiotix Inc. USA |
Year first mentioned: | 2009 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |||||||||||
|
|